A clinical study of adult autoimmune hepatitis in Valencia, Spain;Estudio clínico de la hepatitis autoinmune del adulto en Valencia

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 7, 2008, Pages 400-404

  Garcia Torres M L ^b   Primo, J ^b   Ortuno J A ^c   Martinez M ^d   Anton M D ^e   Zaragoza, A ^f   Gonzalez O ^g   Devesa, F ^h   Merino, C ^b   Del Olmo, Juan A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL DE SAGUNTO   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HÔPITAL DU BOCAGE   (France)

^e Hospital Universitario Doctor Peset   (Spain)

^f HOSPITAL LLUÍS ALCANYÍS   (Spain)

^g HOSPITAL ARNAU DE VILANOVA   (Spain)

^h HOSPITAL FRANCESC DE BORJA   (Spain)

Author keywords

Autoimmune hepatitis diagnosis; Autoimmune hepatitis drug therapy; Autoimmune hepatitis pathology; Epidemiology; Liver cirrhosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE HEPATITIS; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; REMISSION; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 55249100742     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M. Type I autoimmune hepatitis: Patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM 2004; 97: 407-12.
2. Nishioka M, Morshed SA, McFarlane IG. Geographical variation in the frequency and characteristics of autoimmune liver diseases. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases. Amsterdam: Elsevier; 1998. p. 413-24.
3. Czaja AJ, Souto EO, Bittencourt PL, Cancado EL. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 2002; 37: 302-8.
4. Choudhuri G, Somani SK, Baba C, Alexander G. Autoimmune hepatitis in India: Profile of an uncommon disease. BMC Gastroenterol 2005; 5: 27.
5. Homberg JC, Abuaf N, Bernard O, Islam S, Álvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology 1987; 7: 1333-9.
6. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type 1 autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004; 99: 1510-6.
7. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
8. Álvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
9. McFarlane IG. Definition and classification of autoimmune hepatitis. Semin Liver Dis 2002; 22: 317-24.
10. Czaja AJ, Freese DK. AASLD Practice Guidelines. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
11. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
12. Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autimmune hepatitis: A study of 68 patients. J Clin Gastroenterol 2002; 35: 75-81.
13. Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, et al. Clinical features of type 1 autoimmune hepatitis in enderly Italian patients. Aliment Pharmacol Ther 2005; 21: 1273-7.
14. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006; 43: 532-8.
15. García-Romero R, Martín J, Bernal C, Pinillos S, Varea V. Autoimmune hepatitis in pediatric patients. Rev Esp Enferm Dig 2007; 99: 255-8.
16. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005; 42: 53-62.
17. Krawitt EL. Medical progress: Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
18. Manns MP, Vogel A. Autoimmune hepatitis from mechanisms to therapy. Hepatology 2006; 42: S132-44.
19. Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. A J Gastroenterol 2007; 102: 1005-12.
20. Seela S, Sheela H, Boyer JL. Autoimmune Hepatitis type 1: Safety and efficacy of prolonged medical therapy. Liver Int 2005; 25: 734-9.
21. Miyake Y, Iwasaki Y, Terado R, Takagi S, Okamaoto R, Ikeda H, et al. Persistent normalization f serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. J Hepatol 2005; 43: 951-7.
22. Cantarero MD, Gómez J, Menchén L, Pajares JA, LoIacono Q. Liver damage and celiac disease. Rev Esp Enferm Dig 2007; 99: 648-52.